Endothelial progenitor cells (EPC) have significant therapeutic potential. However, the low quantity of such cells available from bone marrow and their limited capacity to proliferate in culture make their use difficult. Here, we present the first definitive demonstration of the presence of true EPC in murine fetal liver capable of forming blood vessels in vivo connected to the host's vasculature after transplantation. This population is particularly interesting because it can be obtained at high yield and has a high angiogenic capacity as compared to bone marrow-derived EPC. The EPC capacity is contained within the CD31 + Sca1 + cell subset. We demonstrate that these cells are dependent for survival and proliferation on a feeder cell monolayer derived from the fetal liver. In addition, we describe a novel and easy method for the isolation and ex vivo proliferation of these EPC. Finally, we used gene expression profiling and tandem mass spectrometry proteomics to examine the fetal liver endothelial progenitors and the feeder cells to identify possible proangiogenic growth factor and endothelial differentiationassociated genes.
Introduction
Endothelial progenitor cells (EPC) have the capacity to proliferate and differentiate into mature endothelial cells. An unexpected and exciting development was the discovery that endothelial progenitors, resident in peripheral blood [1] [2] [3] and bone marrow [4] [5] [6] [7] , can be recruited from the circulation and participate in angiogenesis at sites of tissue injury and/or ischemia [8, 9] . Vascular progenitors can also be isolated from skeletal muscle and can differentiate into endothelial cells during ischemic injuryinduced neovascularization [10] . Similarly, embryonic lung mesenchyme contains endothelial precursors [11] .
Many have suggested the therapeutic potential of progenitor-driven angiogenesis [9] . However, the differentiation of EPC into functional blood vessels in vivo is complex and incompletely understood. For example, what is the biological significance and regulation of angiogenesis mediated by EPC at sites of tissue injury in contrast to angiogenesis mediated by local endothelial cells? Moreover, the quantity of EPC within the circulation, even mobilized from the bone marrow, is low and only a small percentage of CD34 + hematopoietic stem cells have endothelial progenitor capacity [12, 13] .
Therefore, understanding growth factor and cell signal pathways that direct EPC proliferation, survival and differentiation is an important strategy to enrich for angiogenesis-competent cells suitable for clinical applications.
Fetal liver is a source of stem cells that can give rise to hepatocytes and biliary epithelial cells [14, 15] . It is also well established that fetal liver contains Sca1 + hematopoietic stem cells capable of differentiation to myeloid and lymphoid lineages [16] [17] [18] . A subset of fetal liver stem cells has been shown to express endothelial progenitor cell makers in vitro [2, 9, 12] suggesting that they might be EPC. However, this commonly accepted fact has never been proved by demonstration of angiogenesis in vivo mediated directly by participation of these putative EPC. Our interests in the potential of manipulating tissue compartment-specific progenitors as a means of enhancing revascularization of cell transplants during tissue engineering led us to develop a new method to purify stem cells from murine fetal liver. We characterized a minutes. Digestion was stopped by adding 20 ml of HBSS with BSA 0.35% and cooling in ice 10 minutes. After discarding 20 ml of supernatant and adding 5 ml of HBSS+BSA, the pieces were triturated 6 times using a 14G needle attached to a 10 ml syringe. The mixture was then pelleted by centrifugation (99 xg for 30 seconds), 5 ml of buffer was replaced and this entire procedure was repeated twice. The digested tissue pellet was then resuspended in 30 ml of complete RPMI-1640 medium (Cambrex, East Rutherford, New Jersey), 10% fetal calf serum, 4 mM glutamine, 1 mM sodium pyruvate, 100U
penicillin/streptomycin (Invitrogen, Carlsbad, California), split in a 6-well plate with 5 ml per well and cultured at 37 o C and 7% CO 2 . The media was changed every two days. We performed all our studies with cells harvested at 8 days.
Bone marrow stem cell isolation. Bone marrow cells were extracted by flushing from the tibias and femurs of C57Bl/6 mice at 6 to 10 weeks of age. 
Sorting of
[19], Cd34 [20] , Endoglin [21] , c-kit [22] , Aa4 [23] , Vcam-1 [24] . We also designed DNA Microarrays. Affymetrix GeneChip (Santa Clara, California) protocols were used for all hybridizations. Samples were hybridized to MOE430A GeneChip arrays. Data was analyzed using GeneChip Operating Software (GCOS) Version 1.0 from Affymetrix, which computes signal intensity and P values for each probe set (Wilcoxon Rank Sum test) and generates Present/Absent calls. We used RMA Express for signal normalization [25] and BRB ArrayTools for class comparisons (http://linus.nci.nih.gov/BRBArrayTools.html) and Cluster/TreeView for creation of heat map displays [26] .
Microarray data for all the GeneChips are available at the Gene Expression Omnibus 
Multidimensional protein identification technology (MudPIT).
We used multidimensional protein identification technology (MudPIT) for this analysis as described previously [27] . Protein samples were analysed using two different techniques for cleavage. One replicate from each sample was enzymatically cleaved using
Endoproteinase Lys-C (Roche Biochemicals) followed by digestion with sequencing grade modified Trypsin (Promega, Madison, Wisconsin). The other replicate was chemically cleaved with Cyanogen Bromide (CnBr) in addition to enzymatic cleavage with Trypsin and Endoproteinase Lys-C.
Analysis of tandem mass spectra. MS/MS spectra were analyzed using the SEQUEST software analysis protocol as described [28] . A filter, called 2to3 [29] , determined the charge state (+2 or +3) of multiple peptide spectra and poor-quality spectra were deleted.
Each MS/MS spectrum after analysis and filtering was searched against the SwissProt database (Release 42.0) and EntrezProtein (July 24) using SEQUEST [28] . DTASelect was used to filter peptide identifications. Filter criteria were set to Xcorr values >2.2 for 1+ spectra, >2.5 for 2+ spectra and >3.5 for 3+ spectra with DeltCn of 0.1. For the proteins hits of mRNA microarray data, moderate stringency was applied with Xcorrs of >0.8 and Delta Cn of 0.01 followed by manual validation of each peptide spectrum based on two main criteria: 1) more than 3 of the most intense fragment ions must show a match and, 2) the b and y ion series must show continuity for at least 3 fragment ions above background noise.
Statistical analysis. Data are expressed as mean ± standard error (SE) of at least 3 independent experiments. ANOVA was used to detect differences in cells survival and proliferation. A P value of <0.05 was considered statistically significant.
Results

Phenotypic characterization of the isolated LEP.
We developed a novel way to easily isolate a population of cells containing endothelial progenitor cells from mouse fetal livers in large numbers as detailed in the Methods. Between six and twelve days after isolation, weakly adherent and highly light-refractile round cells grow out in clusters on a firmly adherent cell monolayer ( Figure 1A ). We call these round cells LEP (Liver Endothelial Progenitors). We can obtain these cells in large quantity, 5.5±0. One possible concern for use of anti-CD31 staining as a parameter for estimating tissue angiogenesis is that this molecule is also expressed on platelets. To exclude the possibility that marginated platelets and/or postmortem thrombi are contributing to the staining we stained with an antibody reacting with murine integrin αIIbβ3 (Leo.D2), specifically expressed by platelets [32, 33] . The results were that staining with this antibody represents 2 to 3% of the total CD31 staining observed, excluding platelets as a source of error.
That LEP form blood vessels in vivo in the Matrigel post transplant was confirmed by frozen sections of explanted templates stained with the blood vesselspecific anti-vWF antibody ( Figure 3B-D) . The key point is a co-localization between vWF staining and the LEP-derived GFP + cells lining the vascular lumens, which have differentiated into a mature endothelial cell phenotype ( Figure 3D ).
To test whether these new vessels were connected to the host vasculature, we injected the biotinylated endothelium-specific isolectin B4 in the tail vein of NOD/SCID mice two weeks after the transplantation of LEP-containing Matrigel templates. The explanted templates were stained with PE-streptavidin and we showed by flow cytometry that GFP + cells (Tie2 + ) are also isolectin B4 + (data not shown). We obtained the same result by confocal microscopy by staining with streptavidin-Cy5 to identify the biotinylated lectin bound to endothelial cells. Co-localization between the GFP + cells and the isolectin B4 + cells is clearly seen in Figure 2G . In conclusion, the LEP are endothelial progenitor cells, mature into endothelium and incorporate into blood vessels that are connected with the host vasculature after transplantation. . Figure 6 depicts a heat map and cluster analysis of the proangiogenic and anti-angiogenic genes differentially expressed by both LEP subsets. A full set of all differentially expressed genes is available as Supplemental Data (Table S1 ).
Candidate growth factor pathways. LEP depend for survival and proliferation on the underlying feeder cells or their supernatants. We propose that this dependence creates a model system to identify growth factor and differentiation signal pathways for EPC that may also be relevant to angiogenesis. Therefore, we performed gene expression profiling Table S2 ) and demonstrate that 92 out of 124 total genes in this candidate pathway table (74%) are found "Present" by gene expression profiling in the LEP.
We also tested the expression of the candidate genes described above using tandem mass spectrometry proteomics with the Multidimensional Protein Identification Tool (MudPIT) [35] . Thus, we matched the protein candidates identified in LEP (1, 817 proteins) and feeder cells (1,602 proteins) to the 9 growth factor/receptor pathways identified using gene expression profiling (Table S2 ). In total, 75 candidate proteins out of the 124 (60%) in the original set of gene expression-defined pathways were confirmed by MudPIT proteomics.
Discussion
Stem cells have the potential of being tools for tissue engineering and regenerative medicine. A major limitation at the present time is that endothelial progenitor frequency in bone marrow and mobilized peripheral blood cells is extremely low and the efficiency of angiogenesis is poor. Thus, a major challenge is developing strategies to engineer the differentiation and proliferative expansion of endothelial progenitors (EPC) in culture. In the present paper we describe a model of endothelial progenitor cells that is particularly suitable for experiments designed to investigate molecular mechanisms of EPC survival, proliferation and differentiation.
Specifically, we demonstrate that a population of stem cells we have called LEP (Liver Endothelial Progenitors) are found in the murine fetal liver and can be readily Though EPC have been identified in bone marrow, cord and peripheral blood, they represent only a small fraction of the cells in these compartments, typically less than 2% [12, 13, 36] . In contrast, we demonstrate that collagenase digestion of the murine fetal liver is a relatively easy method that yields a large number of readily collected LEP (typically 5.5±0. [36, 38, 39] . VE-cadherin and CD133 are cell surface markers generally agreed upon to be expressed by endothelial progenitors.
We extended our analysis of differential gene expression by using high density DNA microarrays. A large number of genes (228) a bone marrow-derived mouse endothelial progenitor [9] . A number of the up-regulated, angiogenesis-associated genes in the Sca1 + LEP represent candidates for further studies.
Pleiotrophin and Midkine represent a family of mitogenic and angiogenic growth and differentiation factors expressed in cells in early differentiation [40, 41] . The secreted
Frizzled Related sequence Protein-1 (sFRP-1) is strongly expressed during early phases of the vascularization process in embryonic vasculature and modulates vascular cell proliferation [42] . It is interesting that the Frizzled homolog 2 (Fzd2) is also up-regulated in Sca1 + LEP but its precise physiologic function has not been determined yet and so this was not counted in our list of angiogenesis-associated gene candidates [43] . Tweak receptor (Tnfrsf12a) induces angiogenesis in vivo [44] . Laminin alpha4 (lama4) and Nidogen (Nid1) are both up-regulated in Sca1 + LEP and form a stable complex that plays an important modulatory role in angiogenesis [45] . On the other hand, only 6 genes are up-regulated and angiogenesis-associated in the Sca1 -LEP including 3 that are antiangiogenic ( Figure 6 ).
In conclusion, the genomic profiling of LEP Sca1 + versus Sca1 -cells In conclusion, we have proven that Sca1 + endothelial progenitors are found in the fetal liver and that these form blood vessels integrated with the host's vasculature when transplanted in Matrigel templates. We have developed an isolation strategy that is easy and yields a significant number of progenitors for study that proliferate in culture and also have a high efficiency of angiogenesis in vivo. Thus, we suggest that this murine system has promise as a means for advancing studies of endothelial progenitor differentiation, angiogenesis and transplantation. Finally, we have used gene expression profiling and tandem mass spectrometry proteomics as a first approach in identifying candidate genes potentially involved in EPC growth and survival and endothelial differentiation and angiogenesis. 
